Date | Price Target | Rating | Analyst |
---|---|---|---|
3/14/2025 | $45.00 | Buy | Truist |
2/11/2025 | $51.00 | Buy | Jefferies |
11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
7/2/2024 | $27.00 | Buy | BofA Securities |
7/2/2024 | $24.00 | Overweight | Barclays |
7/2/2024 | $27.00 | Buy | Deutsche Bank |
7/2/2024 | $32.00 | Buy | Goldman |
7/2/2024 | $24.00 | Overweight | JP Morgan |
7/2/2024 | $25.00 | Outperform | Evercore ISI |
7/2/2024 | Outperform | William Blair |
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
92% of leaders rank AI and advanced automation as a key focus for overcoming industry challenges Patient Access and Claim Management emerge as the top RCM functions prioritized for automation investment LEHI, Utah and LOUISVILLE, Ky., March 4, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the results of a comprehensive Qualtrics market survey identifying the top revenue cycle management (RCM) trends of 2025. The study surveyed 600 healthcare RCM, finance, and technology leaders from provider organizations of all types and sizes. The findings show that decision-makers are actively prioritizing AI and advanced automation to addres
Latest software innovation automates every step of the authorization submission process, reducing time by 70% and dramatically boosting auto-approval rates LEHI, Utah, and LOUISVILLE, Ky., Feb. 28, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the launch of its Auth Accelerate solution, a major expansion of its advanced automation capabilities designed to streamline the prior authorization process from start to finish. Prior authorizations pose significant challenges across the healthcare spectrum. In response, p
The offering resulted in aggregate gross proceeds of USD920 million, of which EQT received c. USD393 millionNEW YORK, Feb. 24, 2025 /PRNewswire/ -- An affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 23 million shares of common stock of Waystar Holding Corp. (NASDAQ:WAY) (the "Company") ("Shares") for aggregate gross proceeds of USD920 million. As part of the Offering, EQT sold c. 9.8 million Shares (and now holds c. 38.8 million Shares) and received gross proceeds of c. USD393 million. The remaining Shares sold in the Offering were sold by other stockholders of the Company. J.P. Morgan, Goldman Sachs
LEHI, UT. and LOUISVILLE, KY., Feb. 20, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders") at a price to the public of $40.00 per share. Additionally, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock. Waystar is not selling any shares and will no
LEHI, Utah, and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 18,000,000 shares of its common stock being offered by certain investment funds of EQT AB, Canada Pension Plan Investment Board, Bain Capital, LP, and their respective affiliates (collectively, the "Selling Stockholders"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to 2,700,000 additional shares of common stock. Waystar will not receive any proceeds from the sale of shares in
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
Black Book Market Research™ survey of more than a thousand healthcare leaders ranked Waystar #1 in eight categories, more than any other RCM vendor LEHI, Utah and LOUISVILLE, Ky., Feb. 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today announced that it was named by Black Book Market Research™ as the industry's leading AI-powered software platform. Waystar earned #1 rankings in eight key categories, including claim accuracy, operational efficiency, reduction in administrative burden, and patient engagement. The independent survey assessed AI-powered revenue cycle management solutions from 80 vendors, gathering insights from m
Receives multiple Best in KLAS awards in Claims Management & Clearinghouse and Patient Access LEHI, Utah and LOUISVILLE, Ky., Feb. 5, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today announced its top ranking in multiple 2025 Best in KLAS categories: Claims Management & Clearinghouse and Patient Access. Based on independent client feedback, these recognitions underscore the value healthcare providers gain from Waystar's AI-powered software platform, fueled by continuous innovation and a steadfast focus on client satisfaction, empowering providers to tackle the industry's most pressing challenges.
LEHI, Utah and LOUISVILLE, Ky., Jan. 28, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2024, before market open on Tuesday, February 18, 2025. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
LEHI, Utah and LOUISVILLE, Ky., Jan. 28, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2024, before market open on Tuesday, February 18, 2025. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th
Revenue growth of 22% year-over-year Net income of $5.4 million and non-GAAP net income of $25.3 million Net income margin of 2%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky., Nov. 6, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended September 30, 2024. "Waystar delivered another quarter of strong top-line growth," said Matt Hawkins, Chief Executive Officer of Waystar. "Our revenue reached $240 million, representing 22% year-over-year growth, an a
LEHI, Utah and LOUISVILLE, Ky., Oct. 14, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the third quarter ended September 30, 2024, after market close on Wednesday, November 6, 2024. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will
Revenue growth of 20% year-over-year Net loss of $27.7 million and non-GAAP net income of $5.0 million Net loss margin of (11.8)%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky., Aug. 7, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended June 30, 2024. "Waystar delivered strong performance across all key metrics in Q2," said Matt Hawkins, Chief Executive Officer of Waystar. "We have solid momentum as clients utilize the cloud-based Waystar software platform, which we have purpose-built to drive client return on investment and a differentiated, modern user experien
LEHI, Utah and LOUISVILLE, Ky., July 17, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today it will report financial results for the second quarter ended June 30, 2024, after market close on Wednesday, August 7, 2024. Waystar's financial results will be discussed on a conference call scheduled at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real-time. About WaystarWaystar's mission-critical software is p
144 - Waystar Holding Corp. (0001990354) (Subject)
SCHEDULE 13G/A - Waystar Holding Corp. (0001990354) (Subject)
424B7 - Waystar Holding Corp. (0001990354) (Filer)
EFFECT - Waystar Holding Corp. (0001990354) (Filer)
S-1MEF - Waystar Holding Corp. (0001990354) (Filer)
S-1 - Waystar Holding Corp. (0001990354) (Filer)
10-K - Waystar Holding Corp. (0001990354) (Filer)
8-K - Waystar Holding Corp. (0001990354) (Filer)
8-K - Waystar Holding Corp. (0001990354) (Filer)
144 - Waystar Holding Corp. (0001990354) (Subject)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00
BofA Securities initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $27.00
Barclays initiated coverage of Waystar Holding Corp. with a rating of Overweight and set a new price target of $24.00
Deutsche Bank initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $27.00
Goldman initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $32.00
JP Morgan initiated coverage of Waystar Holding Corp. with a rating of Overweight and set a new price target of $24.00
Evercore ISI initiated coverage of Waystar Holding Corp. with a rating of Outperform and set a new price target of $25.00
William Blair initiated coverage of Waystar Holding Corp. with a rating of Outperform
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
3 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)